Vantage Consulting Group Inc - Q2 2023 holdings

$174 Million is the total value of Vantage Consulting Group Inc's 216 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .

 Value Shares↓ Weighting
BW NewBABCOCK & WILCOX ENTERPRISES$14,255,5802,416,200
+100.0%
8.20%
NewCIBUS INC$13,259,8421,262,842
+100.0%
7.63%
PANW NewPALO ALTO NETWORKS INC$253,721993
+100.0%
0.15%
CI NewTHE CIGNA GROUP$207,644740
+100.0%
0.12%
SWK NewSTANLEY BLACK & DECKER INC$203,2572,169
+100.0%
0.12%
COTY NewCOTY INC$127,73010,393
+100.0%
0.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ROYALTY PHARMA PLC12Q3 202387.5%
ADC THERAPEUTICS SA SHS12Q3 20239.8%
FIBROGEN INC12Q3 20235.7%
COSTCO WHSL CORP NEW12Q3 20230.5%
WALMART INC12Q3 20230.5%
Sysco Corporation12Q3 20230.5%
Exxon Mobil Corporation12Q3 20230.5%
Chevron Corporation12Q3 20230.5%
KROGER CO12Q3 20230.5%
CVS Health Corporation12Q3 20230.5%

View Vantage Consulting Group Inc's complete holdings history.

Latest significant ownerships (13-D/G)
Vantage Consulting Group Inc Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SYNTAX ETF TRUSTSeptember 11, 2023717,13252.2%
SYNTAX ETF TRUSTNovember 08, 2022156,13356.8%
SYNTAX ETF TRUSTSold outJune 24, 2021012.4%

View Vantage Consulting Group Inc's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
SC 13G/A2023-09-11
13F-HR2023-08-11
13F-HR2023-05-10
13F-HR2023-02-13
13F-HR2022-11-14
SC 13G/A2022-11-08
SC 13G/A2022-10-04

View Vantage Consulting Group Inc's complete filings history.

Compare quarters

Export Vantage Consulting Group Inc's holdings